Head-to-head · WeighScore
Risen Labs vs TeleClinic
The verdict
TeleClinic takes it — 60.8/100 to 57.2/100.
TeleClinic grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TeleClinic (Teleclinic Holdings LLC) is a US telehealth platform offering physician-prescribed compounded GLP-1 weight-loss medication — semaglutide and tirzepatide — shipped from a licensed 503A…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Risen Labs | TeleClinic |
|---|---|---|
| WeighScore | 57.2/100 | 60.8/100 |
| Grade | C | C |
| Scorecard rank | #403 | #314 |
| Semaglutide | Not disclosed | $199/mo (compounded) |
| Tirzepatide | Not disclosed | $299/mo (compounded) |
| Coverage | 2 states | 47 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #403 · C
Strengths
- Names its compounding pharmacy (Olympia Pharmacy, a 503A compounding pharmacy) and legal entity (Risen Labs LLC)
- Offers compounded semaglutide and tirzepatide as clinician-guided once-weekly injections
- Focused clinical intake covering weight loss, men's health, and hormone protocols
Where it loses points
- GLP-1 pricing is not published; it appears only after you complete the clinical intake
- Available only to patients in New York and Colorado
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
- No LegitScript certification is displayed on the site
Graded #314 · C
Strengths
- Names its pharmacy partner — Rush Pharmacy, a licensed 503A compounder — which many compounded-GLP-1 telehealths won't disclose
- LegitScript certified with flat, published monthly pricing, free shipping, and no insurance required
- Broad access: 47 states with US-licensed physicians and transparent cash-pay pricing
Where it loses points
- Compounded semaglutide and tirzepatide only — no brand-name GLP-1 (Wegovy or Zepbound) option
- Headline $139/$219 rates are first-quarter intro prices billed quarterly; ongoing month-to-month is $199/$299
- Not available in California, South Carolina, or New Jersey
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.